Endothelin-1 Levels in Interstitial Lung Disease Patients During Sleep

Georgia Trakada; Eugenia Nikolaou; Athanasia Pouli; Maria Tsiamita; Kostas Spiropoulos

doi:10.1055/s-2003-43072

Sleep and Breathing, Table of Contents

Sleep Breath 2003; 07(3): 111-118
DOI: 10.1055/s-2003-43072

ORIGINAL ARTICLE

Endothelin-1 Levels in Interstitial Lung Disease Patients During Sleep

Georgia Trakada¹ , Eugenia Nikolaou² , Athanasia Pouli³ , Maria Tsiamita¹ , Kostas Spiropoulos¹

¹University of Patras Medical School, Division of Pulmonology, Laboratory of Sleep, Patras, Greece
²Laboratory of Immunology, Onashion Cardiosurgery Hospital, Athens, Greece
³Department of Hematological Diseases, Agios Sabas Hospital, Athens, Greece

Abstract

ABSTRACT

Background: Hypoxemia stimulates endothelin-1 (ET-1) secretion. The reduction in alveolar ventilation during sleep is considered sufficient to account for the hypoxemia observed in patients with respiratory diseases. Objective: The aim of this study was to evaluate the arterial ET-1 levels and their relationship with pulmonary hypertension in patients with interstitial lung disease (ILD) during sleep. Methods: We examined 38 patients with ILD using formal polysomnography (electroencephalogram, electrocardiogram, airflow, respiratory muscle movement, oximeter) to detect the presence of nocturnal, nonapneic, oxyhemoglobin desaturation. All patients desaturated below a baseline sleep saturation of 90% for 5 minutes or more, reaching a nadir saturation of at least 85%. Each patient had already undergone right heart catheterization with a Swan-Ganz catheter for measuring hemodynamic parameters. Sampling of arterial blood from a radial artery line for determination of blood gases and ET-1 values was performed simultaneously, after 5 minutes of the first desaturation. Results: At rest, arterial ET-1 levels were higher in ILD patients (1.73 ± 0.37 mgr/mL) than in controls (1.22 ± 0.15 mgr/mL) (p < 0.001). Also, the patients with pulmonary hypertension (Pa > 20 mm Hg) presented significantly higher arterial ET-1 levels (1.86 ± 0.32 mgr/mL) than those without pulmonary hypertension (1.31 ± 0.13 mgr/mL) (p < 0.001). Arterial ET-1 levels were significantly correlated with mean pulmonary arterial pressure (PAP) (r = 0.749, p < 0.001), and arterial oxygen partial pressure (PaO₂) (r = 0.79, p < 0.001). At sleep, during desaturation, arterial ET-1 levels significantly increased in all patients (2.46 ± 0.13 mgr/mL) as compared with resting values (p < 0.001). Arterial ET-1 levels were significantly correlated with PAP (r = 0.657, p < 0.001) and PaO2 (r = 0.93, p < 0.001). Conclusions: According to our study, arterial ET-1 is markedly increased in ILD patients, especially in those with pulmonary hypertension.

KEYWORDS

Interstitial lung disease - sleep - endothelin-1 (ET-1) - hypoxemia

Full Text

References

REFERENCES

1 Inoue A, Yanagisawa S, Kimura Y. et al . The human endothelin family; three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA . 1989; 86 2863-2867
2 Giaid A, Michel R P, Stewart D J, Sheppard M, Corria B, Hamid Q. Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis. Lancet . 1993; 341 1550-1554
3 Giaid A, Yanagisawa M, Langleben D. et al . Expression of endothelin-1 in lungs of patients with pulmonary hypertension. N Engl J Med . 1993; 328 1732-1739
4 Shirakami G, Nakap K, Saito Y. et al . Acute pulmonary alveolar hypoxia increases lung and plasma endothelin-1 levels in conscious rats. Life Sci . 1991; 48 969-976
5 Trask C H, Gree E M. Oximeter studies on patients with chronic obstructive emphysema, awake and during sleep. N Engl J Med . 1962; 266 639-642
6 Koo K W, Sax D S, Snider G L. Arterial blood gases and pH during sleep in chronic obstructive pulmonary disease. Am J Med . 1975; 58 663-670
7 Wynne J W, Block A J, Hemenway I, Hunt L A, Flick M R. Disordered breathing and oxygen desaturation during sleep in patients with chronic obstructive lung disease (COLD). Am J Med . 1979; 66 573-579
8 Trakada G, Marangos M, Spiropoulos K. Mechanisms of endothelin-1 elevation in chronic obstructive pulmonary disease patients with nocturnal oxyhemoglobin desaturation. Respiration . 2001; 68(2) 134-139
9 Francis P W, Muller N L, Gurwitz D, Milligan D W, Levison H, Bryan A C. Hemoglobin desaturation: its occurrence during sleep in patients with cystic fibrosis. Am J Dis Child . 1980; 134 734-740
10 Stokes D C, McBride J T, Wall M A, Erba G, Strieder D J. Sleep hypoxemia in young adults with cystic fibrosis. Am J Dis Child . 1980; 134 741-743
11 Bye P T, Issa F, Berthon-Jones M, Sullivan C E. Studies of oxygenation during sleep in patients with interstitial lung disease. Am Rev Respir Dis . 1984; 129 27-32
12 Perez-Padilla R, West P, Lertzman M, Kryger M H. Breathing during sleep in patients with interstitial lung disease. Am Rev Respir Dis . 1985; 132 224-229
13 Mezon B L, West P, Israels J, Kryger M. Sleep breathing abnormalities in kyphoscoliosis. Am Rev Respir Dis . 1980; 122 617-621
14 Guilleminault C, Motta J. Sleep apnea syndrome as a long-term sequela of poliomyelitis. In: Guilleminault C, Dement WC, eds. Sleep Apnea Syndromes New York, NY: Alan R Liss 1978: 309-315
15 Douglas N J, Calverley P M, Leggett R J, Brash H M, Flenley D C, Brezinova V. Transient hypoxaemia during sleep in chronic bronchitis and emphysema. Lancet . 1979; 1 1-4
16 Boysen P G, Block J A, Wynne J W, Hunt L A, Flick M R. Nocturnal pulmonary hypertension in patients with obstructive pulmonary disease. Chest . 1979; 76 536-542
17 Fletcher E C, Levin D C. Cardiopulmonary haemodynamics during sleep in subjects with chronic obstructive pulmonary disease: the effect of short- and long-term oxygen. Chest . 1984; 85 6-14
18 Flenley D C. Clinical hypoxia: causes, consequences and correction. Lancet . 1978; 1 542-546
19 Block A J, Boyson P G, Wynne J W. The origins of cor pulmonale, a hypothesis. Chest . 1979; 75 109-110
20 Rechtshaffen A, Kales A. A Manual of Standarized Terminology, Techniques and Scoring Systems for Sleep Stages of Human Subjects Publication 204. Washington, DC: National Institutes of Health 1968
21 Luscher T F. Endothelin [review]. J Cardiovasc Pharmacol . 1991; 18 (suppl 10) S15-S22
22 Hay D PW, Henry P J, Goldie R G. Endothelin and the respiratory system. Trends Pharmacol Sci . 1993; 14 29-32
23 Trakada G, Tsourapis S, Marangos M, Spiropoulos K. Arterial and bronchoalveolar lavage fluid endothelin-1 concentration in asthma. Respir Med . 2000; 10 992-996
24 Langleben D, Demarchie M, Laporta D. et al . Endothelin-1 in acute lung injury and the adult distress syndrome. Am Rev Respir Dis . 1993; 148 1646-1650
25 Lippton H L, Hauth T A, Summer W R, Hyman A L. Endothelin produces pulmonary vasoconstriction and systemic vasodilation. J Appl Physiol . 1989; 66 1008-1012
26 Marhewitz B A, Kohan D E, Michael J R. Endothelin-1 synthesis, receptors and signal tranduction in alveolar epithelium: evidence for an autocrine role. Am J Physiol . 1995; 268 L192-L200
27 Komuro I, Kurihara H, Sugiyama T, Yoshizumi M, Tahaku F, Yazaki Y. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett . 1988; 238 249-252
28 Trakada G, Spiropoulos K. Arterial endothelin-1 in interstitial lung disease patients with pulmonary hypertension. Monaldi Arch Chest Dis . 2001; 56 379-383
29 Bullow K. Respiration and wakefulness in man. Acta Physiol Scand . 1963; 59 1-110
30 Douglas N J, White D P, Pickett C K, Weil J V, Zwillich C W. Respiration during sleep in normal man. Thorax . 1982; 37 840-844
31 Catterall J R, Douglas N J, Carverley P M. et al . Transient hypoxemia during sleep in chronic obstructive pulmonary disease is not a sleep apnea syndrome. Am Rev Respir Dis . 1983; 128 24-29
32 Gould G A, Gugger M, Molloy J, Tsara V, Shapiro C M, Douglas N J. Breathing pattern and eye movement density during REM sleep in humans. Am Rev Respir Dis . 1988; 138 870-874